Trial · NCT07275320
Cervical Retrolaminar Block Versus Cervical Epidural Injection for Cervical Radiculopathy
NCT07275320, Not applicable, Completed, Istanbul Medeniyet University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Cervical Retrolaminar Block Versus Cervical Epidural Injection for Cervical Radiculopathy. Trials, record NCT07275320. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07275320
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Cervical Retrolaminar Block Versus Cervical Epidural Injection for Cervical Radiculopathy
- NCT number
- NCT07275320
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 70 participants, actual
- Lead sponsor
- Istanbul Medeniyet University
- Conditions
- Cervical Radiculopathy
- Interventions
- Fluoroscopy-guided cervical interlaminar epidural injection, Cervical Retrolaminar Block, Bupivacaine 0.25%, Dexamethasone
- First posted
- 2025-12-10
- Last updated
- 2025-12-11
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in pain intensity assessed by the Visual Analog Scale (VAS) | At baseline and at 1, 4, 8, and 12 weeks after the procedure. | Pain intensity will be assessed in both groups using a 10-cm Visual Analog Scale (VAS), where 0 indicates "no pain" and 10 indicates "worst imaginable pain." VAS scores will be recorded before the procedure (baseline) and at 1, 4, 8, and 12 weeks after the intervention. The primary outcome is the change in VAS pain scores from baseline at 1, 4, 8, and 12 weeks and the comparison of these changes between the two treatment groups. |
| Secondary | Change in Neck Disability Index (NDI) score | At baseline and at 1, 4, 8, and 12 weeks after the procedure. | Functional disability will be evaluated using the Neck Disability Index (NDI). NDI scores will be recorded in both groups before the procedure (baseline) and at 1, 4, 8, and 12 weeks after the intervention. The secondary outcome is the change in NDI score from baseline at 1, 4, 8, and 12 weeks and the comparison of these changes between the two treatment groups. |
| Secondary | Incidence of treatment-related adverse events in both groups | Day of the procedure (baseline) to 12 weeks after the intervention | All procedure-related adverse events were recorded in both groups from the day of the procedure to 12 weeks after the intervention. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07275320
GET https://conductscience.org/api/trials/v1/NCT07275320/registered